Kumeria et al. showed that their microchip IRS-based immunosensor (NAA-biotinylated anti-epithelial cell adhesion molecule antibody (anti-EpCAM)) can be used for sensing circulating tumor cells (CTCs) within 5 min [128]. The gene discussed is EPCAM; the disease is neoplasm.